Health
Metformin use reduces risk of death for patients with Covid-19, diabetes – Hindustan Times
Use of the diabetes drug metformin, before a diagnosis of Covid-19 is associated with a threefold decrease in mortality in Covid-19 patients with Type 2 diabetes,…
Use of the diabetes drug metformin — before a diagnosis of Covid-19 is associated with a threefold decrease in mortality in Covid-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham.
Diabetes is a significant comorbidity for Covid-19.
“This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure,” said Anath Shalev, M.D., director of UAB’s Comprehensive…
Continue Reading
